Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB/IIA Study of the Safety and Activity of Intravenous Isophosphoramide Mustard (ZIO-201) in Patients With Advanced Sarcoma

NCT00439686 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

NCT NCT00439686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00439686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB/IIA Study of the Safety and Activity of Intravenous Isophosphoramide Mustard (ZIO-201) in Patients With Advanced Sarcoma
Lead sponsor
Alaunos Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
February 21, 2006
Completion date
January 16, 2008
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced sarcoma